Glaxosmithkline introduces tiered price scheme for vaccines

This week GSK announced it was introducing a tiered price scheme for the vaccine Rotarix, a vaccine that prevents a disease that causes diarrhea and kills around half a million children a year. The vaccine will be made available in developing countries for 1.50 GBP instead of the 30 GBP it currently costs in developed countries. This reflects the growing trend towards social responsibility on a global scale.

See Interesting links - Glaxosmithkline - introduce tiered price scheme for vaccine